Intrinsic Edge Capital Management’s Zimmer Biomet ZBH Stock Holding History

Intrinsic Edge Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-182,672	Closed	-$26.6M	–	209
2023 Q2	$26.6M	Buy	182,672 +92,672	+103%	+$12.6M	1.91%	5
2023 Q1	$11.6M	Buy	+90,000	New	+$11.3M	1.17%	26
2021 Q4	–	Sell	-18,128	Closed	-$2.58M	–	281
2021 Q3	$2.58M	Buy	+18,128	New	+$2.67M	0.18%	164
2020 Q3	–	Sell	-20,600	Closed	-$2.39M	–	293
2020 Q2	$2.39M	Hold	20,600	–	–	0.22%	154
2020 Q1	$2.02M	Buy	+20,600	New	+$2.7M	0.27%	107

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Intrinsic Edge Capital Management's ZBH Position: Q3 2023 in Review

Intrinsic Edge Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 182,672 shares — an estimated $26.6M sold.

Intrinsic Edge Capital Management first reported a position in ZBH in Q1 2020 and held it in 5 quarters. The position peaked at $26.6M in Q2 2023. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Intrinsic Edge Capital Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Intrinsic Edge Capital Management sold 182,672 Zimmer Biomet shares in Q3 2023, an estimated $26.6M.
Intrinsic Edge Capital Management first reported a position in Zimmer Biomet in Q1 2020 and held it in 5 quarters.
Intrinsic Edge Capital Management's Zimmer Biomet position peaked at $26.6M in Q2 2023.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.